Women’s Health and Beauty Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 – 2030
The global Women’s Health and Beauty Supplements market size is expected to be worth around US$ 80.6 billion by 2030, according to a new report by Vision Research Reports.
The global Women’s Health and Beauty Supplements market size was valued at US$ 55.0 billion in 2020 and is anticipated to grow at a CAGR of 5.9% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38899
Report Coverage
| Report Scope | Details |
| Market Size | US$ 80.6 Billion by 2030 |
| Growth Rate | CAGR of 5.9% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Application, Age Group, Consumer Group, Sales Channel |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Amway; Herbalife International of America Inc.; GNC Holdings Inc.; The Nature’s Bounty Co.; Bayer AG; Garden of Life (Nestle); Suntory Holdings Limited; Taisho Pharmaceutical Co. Ltd.; Swisse Wellness Pty. Ltd.; Pharmavite LLC; Pfizer Inc.; Blackmores; Fancl Corporation; Asahi Group Holdings; Usana Health Sciences; Nu Skin Enterprises; By Health Co. Ltd; Revital Ltd.; The Himalaya Drug Company; Vita Life Sciences; Grape King Bio Ltd.; Standard Foods Corporation |
Growth Factors
Rising awareness levels about health and wellness along with the growing adoption of an active lifestyle are expected to boost product demand. Women are shifting their focus towards preventative healthcare and consuming vitamins and minerals. In addition, the COVID-19 pandemic has boosted the awareness of physical, mental, and emotional health and increased the implementation of self-care among consumers. This, in turn, has increased the adoption of health and beauty supplements. Consumers have started adopting vitamins, minerals, and botanicals to boost immunity.
By Product Analysis
The vitamins product segment accounted for the largest revenue share of over 37% in 2020 owing to the increased demand for immunity-boosting vitamins, such as vitamin C, D, and B, during the COVID-19 pandemic.
vitamin A is known to play a crucial role in the formation of organs, such as the lungs, kidneys, and heart of the fetus. However, the enzymes segment is expected to grow at the fastest CAGR over the forecast period due to the growing demand for Co-Enzyme Q10. Co-Enzyme Q10 is used widely in skin repair and cellular rejuvenation applications.
By Application Analysis
The women’s health application segment held the highest market share of more than 68% in 2020 and is also estimated to register the fastest CAGR during the forecast period. This growth is attributed to the availability of a variety of supplements for different conditions, such as prenatal, postnatal, bone & joint health, immune system, digestive system health, stress management, heart health, eye health, sexual health, and memory.
The increasing cases of vitamin, iron and other nutritional deficiencies among women are also supporting the segment growth. Moreover, a rise in the need for nutrients, mainly in prenatal, premenstrual, and perimenopause stages, is estimated to drive the segment growth. Consumption of immunity-boosting products has increased during the pandemic.
By Age Group Analysis
The age group 30 – 50 years segment held the highest market share of more than 42% in 2020. The high adoption of preventative medicines and the presence of a large consumer pool is major factor responsible for the high market share of this segment.
the above 70 years segment is estimated to register the fastest CAGR during the forecast period. It is attributed to the growing geriatric population. According to United Nations, the women population aged 80 years and above will reach 59% of the total population.
By Consumer Group Analysis
The others segment held the highest market share of 32.6% in 2020. A significant number of adolescent girls are reported to be underweight, and adequate intake of dietary supplements has been shown to improve their overall health.
the post-natal segment is estimated to register the fastest CAGR during the forecast period. Many women consume supplements to lose post-partum weight and maintain a healthy lifestyle.
women are looking for achieving adequate nutrient intake during the lactation phase. In addition, post-natal depression can be prevented by adequate nutrient intake. All the above-mentioned parameters are estimated to drive the post-natal segment growth during the forecast period.
By Sales Channel Analysis
The direct sales channel segment accounted for the largest revenue share of 35% in 2020. This is owing to the high consumer preference and trust for direct sales channels over other channels. Moreover, the direct sales channel offers lucrative discounts and flexible schemes.
the online segment is expected to grow at the fastest CAGR over the forecast period owing to a high preference for online channels and growing adoption of e-commerce platforms. There is a growing trend of personalization of vitamins and other nutrients.
By Regional Analysis
Asia Pacific accounted for the highest revenue share of 38.9% in 2020, due to the increased awareness and adoption of women’s health and beauty supplements, and high disposable income & number of working women.
Middle East & Africa is anticipated to register the fastest CAGR during the forecast period. The increasing number of instances of nutritional deficiencies, the growing concerns about lifestyle disorders, and rising product awareness are estimated to drive the regional markets.
Key Players
- Amway
- Herbalife International of America, Inc.
- GNC Holdings, Inc.
- The Nature’s Bounty Co.
- Bayer AG; Garden of Life (Nestle)
- Suntory Holdings Ltd.
- Taisho Pharmaceutical Co. Ltd.
- Swisse Wellness Pty. Ltd.
- Pharmavite LLC
- Pfizer, Inc.
- Blackmores
- Fancl Corp.
- Asahi Group Holdings
- Usana Health Sciences
- Nu Skin Enterprises
- BY-Health Co. Ltd.
- Revital Ltd.
- The Himalaya Drug Company
- Vita Life Sciences
- Grape King Bio Ltd.
- Standard Foods Corp.
Market Segmentation
- By Product
- Vitamins
- Mineral
- Enzymes
- Botanicals
- Proteins
- Omega-3
- Probiotics
- Others
- By Application
- Beauty
- Women’s Health
- Skin Care
- Nail Care
- Hair Care
- Others
- By Age Group
- Age 15 – 30
- Age 31 – 50
- Age 51 – 70
- Above 70 years
- By Consumer Group
- Prenatal
- Postnatal
- PMS
- Perimenopause
- Postmenopause
- Others
- By Sales Channel
- Online
- Direct Sales
- Pharmacies/Drug Stores
- Other offline channels
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Taiwan
- Malaysia
- Thailand
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38899
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Women’s Health and Beauty Supplements Market, By Product
7.1. Women’s Health and Beauty Supplements Market, by Product, 2021-2030
7.1.1. Vitamins
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Mineral
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Enzymes
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Botanicals
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Proteins
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. Omega-3
7.1.6.1. Market Revenue and Forecast (2017-2030)
7.1.7. Probiotics
7.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Women’s Health and Beauty Supplements Market, By Application
8.1. Women’s Health and Beauty Supplements Market, by Application, 2021-2030
8.1.1. Beauty
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Women’s Health
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Women’s Health and Beauty Supplements Market, By Age-Group
9.1. Women’s Health and Beauty Supplements Market, by Age-Group, 2021-2030
9.1.1. Age 15 – 30
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Age 31 – 50
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Age 51 – 70
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Above 70 years
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Women’s Health and Beauty Supplements Market, By Consumer Group
10.1. Women’s Health and Beauty Supplements Market, by Consumer Group, 2021-2030
10.1.1. Prenatal
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Postnatal
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. PMS
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Perimenopause
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Postmenopause
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Women’s Health and Beauty Supplements Market, By Sales Channel
11.1. Women’s Health and Beauty Supplements Market, by Sales Channel, 2021-2030
11.1.1. Online
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Direct Sales
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Pharmacies/Drug Stores
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Other offline channels
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Women’s Health and Beauty Supplements Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.1.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.1.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.1.6.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.1.7. Rest of North America
12.1.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.7.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.1.7.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.1.7.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.2.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.2.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.2.6.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.2.7. Germany
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.2.7.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.2.8. France
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.2.8.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.2.9. Rest of Europe
12.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.9.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.9.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.2.9.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.2.9.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.3.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.3.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.3.6.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.3.7. China
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.3.7.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.3.8. Japan
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.3.8.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.3.9. Rest of APAC
12.3.9.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.9.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.9.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.3.9.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.3.9.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.4.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.4.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.4.6.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.4.7. North Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.4.7.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.4.8. South Africa
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.4.8.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.4.9. Rest of MEA
12.4.9.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.9.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.9.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.4.9.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.4.9.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.5.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.5.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.5.6.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
12.5.7. Rest of LATAM
12.5.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.7.3. Market Revenue and Forecast, by Age-Group (2017-2030)
12.5.7.4. Market Revenue and Forecast, by Consumer Group (2017-2030)
12.5.7.5. Market Revenue and Forecast, by Sales Channel (2017-2030)
Chapter 13. Company Profiles
13.1. Amway
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Herbalife International of America, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. GNC Holdings, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. The Nature’s Bounty Co.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Bayer AG; Garden of Life (Nestle)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Suntory Holdings Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Taisho Pharmaceutical Co. Ltd.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Swisse Wellness Pty. Ltd.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Pharmavite LLC
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Pfizer, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38899
Contact Us:
Vision Research Reports
Call: +1 9197 992 333